Optimize your mRNA process from pDNA template to LNP encapsulation
Sponsor
mRNA-based therapeutics represent a promising new modality for therapies and vaccines. However, process understanding of the CQA and CPP interplay is still developing across the industry. As such, the lack of immediate feedback on the process state during process optimization, sometimes delayed by weeks and limited by throughput, represents a major bottleneck in mRNA commercialization.
The PATfix™ mRNA analytical platform enables reliable at-line insight during process development and production of mRNA-based therapeutics. The ability to resolve key IVT reaction components (NTPs, capping reagent, template, and mRNA), allows both USP and DSP process insight, with a single analytical tool.
The PATfix mRNA platform has now been upgraded to include LNP encapsulation analytics, enabling at-line monitoring of a crucial process step on the path from mRNA drug substance to LNP drug product.
Attend this webinar to discover more about:
- The importance of at-line process analytics for process development and production of mRNA vaccines and therapeutics
- How a new analytical platform can help process developers optimize their mRNA production and purification processes for better yields, recoveries, and purity
- Three orthogonal analytical methods based on mix-mode, affinity, and reverse phase chromatography, allow for precise quantification and mRNA sample characterization
SPEAKERS
You might also like
Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME
Pure and simple: understanding LNP analytics for better mRNA-based drugs
Empowering patient care: in-process and quality control solutions for cellular therapies
T cells from beginning to end: optimizing leukopak and drug product cryopreservation
